Challenges and opportunities for IBD drug development: from early stage to regulatory approval-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Challenges and opportunities for IBD drug development: from early stage to regulatory approval

Published:2020-03-16 Issue:7 Volume:69 Page:1157-1161
ISSN:0017-5749
Container-title:Gut
language:en
Short-container-title:Gut

Author:

Danese Silvio^ORCID,Schabel Elmer,Ainsworth Mark Andrew,Peyrin-Biroulet Laurent^ORCID

Publisher

BMJ

Subject

Gastroenterology

Reference26 articles.

1. Novel treatments for inflammatory bowel disease;Lee;Korean J Intern Med,2018

2. Fast-track drug approval in inflammatory bowel diseases;Katsanos;Ann Gastroenterol,2016

3. European Medicines Agency . Accelerated assessment. European Medicines Agency, 2019.

4. The Cost of Inflammatory Bowel Disease: An Initiative From the Crohn's & Colitis Foundation;Park;Inflamm Bowel Dis,2020

5. Market share and costs of biologic therapies for inflammatory bowel disease in the USA;Yu;Aliment Pharmacol Ther,2018

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. FORWARD: A Learning Framework for Logical Network Perturbations to Prioritize Targets for Drug Development;2024-07-19

2. Unveiling Colitis: A Journey through the Dextran Sodium Sulfate-induced Model;Inflammatory Bowel Diseases;2024-01-27

3. Lactiplantibacillus plantarum ZJ316–fermented milk ameliorates dextran sulfate sodium–induced chronic colitis by improving the inflammatory response and regulating intestinal microbiota;Journal of Dairy Science;2023-11

4. Crossing barriers: the burden of inflammatory bowel disease across Western Europe;Therapeutic Advances in Gastroenterology;2023-01

5. Review article: randomised controlled trials in inflammatory bowel disease—common challenges and potential solutions;Alimentary Pharmacology & Therapeutics;2022-02-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3